It could, instead, potentially increase the risk of circulatory issues, such as varicose veins and deep vein thrombosis.

The condition, known as Cavernous Sinus Thrombosis, kills 30 percent of those who contract it. Strom notes that while ...

Columnist Jennifer Lynne attends the recent One Drop conference, which focused on ultrarare bleeding disorders.

A recent study by scientists at the Center for Research on Redox Processes in Biomedicine (Redoxoma) has shed light on why ...

An 81-year-old woman with a 2-day history of vomiting and abdominal distension attended our hospital. The patient reported no fever, recent travel abroad, or change of bowel habit. She had a 3-year ...

A study conducted at the Center for Research on Redox Processes in Biomedicine (Redoxoma) helps understand how high blood sugar (hyperglycemia), one of the manifestations of diabetes, can cause ...

Dyson Koehler had what has been a minor setback in the leadup to his fifth and final college basketball season, needing a ...

Two-year outcomes were reported from the CLOUT registry, which is a prospective, multicenter study evaluating patient ...

Venous disorders occur practically everywhere in the world. They form a highly heterogeneous group and even seemingly banal ...

Antithrombin, a plasma protein, has been reported to control thrombin activity by directly binding to thrombin, as well as to ...

Pegcetacoplan reduced thrombosis rates in PNH to 0.32 events per 100 patient-years. Real-world evidence presented at the NORD Breakthrough Summit, October 20 to 22, 2024, in Washington, DC, showed ...